ExodusPoint Capital Management, LP - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q2 2023$8,572
-97.7%
284,700
+1723.8%
0.07%
+1300.0%
Q3 2022$377,000
-88.1%
15,610
-84.0%
0.01%
-89.1%
Q1 2021$3,162,000
+281.9%
97,288
+331.0%
0.05%
+119.0%
Q2 2020$828,000
-75.9%
22,575
-83.2%
0.02%
-84.7%
Q2 2019$3,435,000134,4000.14%
Other shareholders
VANECK VECTORS ETF TR shareholders Q4 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders